Polyplus-transfection Breaking News Immatics Prices $150M Stock Offering Arrivo BioVentures to Explore Biomarkers in Phase I Trial of Drug Candidate for Depression in Women FDA Approves Genentech's Itovebi Combo for PIK3CA-Mutated Advanced Breast Cancer Patients In Brief This Week: ADLM, Verismo, Gemma, Denovo, Flatiron Health, Foresight, Naveris Foundation Medicine Test Approved by FDA as CDx for Itovebi in Breast Cancer Patients Burning Rock, Dizal Get Chinese Approval for Lung Cancer CDx